Skip to main content
main-content

Editor's pick

16-10-2020 | Rheumatoid arthritis | News

Mood disorders linked to biologic initiation, switching in rheumatic diseases

Depression and anxiety are significantly associated with the introduction and switching of biologic DMARDs in patients with inflammatory rheumatic diseases, population-based study data show.

13-10-2020 | COVID-19 | News

RECOVERY: Hydroxychloroquine does not prevent COVID-19 deaths

Treatment with hydroxychloroquine does not reduce 28-day mortality risk among patients hospitalized with COVID-19, show results from the large-scale UK-based RECOVERY trial.

14-10-2020 | Devices and technology | Editorial | Article

Use of wearable activity trackers to detect disease flares in rheumatic diseases

Antsa Rakotozafiarison and Laure Gossec explore how wearable activity trackers coupled with machine learning can be used to monitor flares in people with rheumatic diseases.

Latest from across the site

22-10-2020 | COVID-19 | News

Early RCT evidence suggests tocilizumab may not be beneficial for COVID-19

Findings from three randomized controlled trials suggest that treatment with the IL-6 inhibitor tocilizumab has little benefit for hospitalized patients with COVID-19.

22-10-2020 | Rheumatoid arthritis | News

Support for further investigation of otilimab in rheumatoid arthritis

Otilimab, a human monoclonal antibody that inhibits GM-CSF, may warrant further investigation for the treatment of rheumatoid arthritis, indicate findings from two phase 2 trials published in The Lancet Rheumatology.

21-10-2020 | COVID-19 | News

COVID-19 lockdown had ‘immediate negative consequences’ for rheumatology patients

Over half of a UK cohort of rheumatology patients experienced worsening in musculoskeletal symptoms during the COVID-19 lockdown period, say researchers.

20-10-2020 | Osteoarthritis | News

Outpatient rehabilitation no better than home exercise for TKA recovery

Outpatient therapist-led rehabilitation offers no clinical benefit over a home-based exercise regimen in patients with knee osteoarthritis at risk for poor outcomes after total knee arthroplasty, shows the TRIO trial.

19-10-2020 | COVID-19 | News

Recommendations made for offsetting negative effects of COVID-19 on rheumatology practice

Better access to treatment and a dedicated telemedicine platform are among the suggestions made to remedy the negative impact the COVID-19 pandemic has had on rheumatology practice in Arab countries, following results from a recent survey.

16-10-2020 | Rheumatoid arthritis | News

Mood disorders linked to biologic initiation, switching in rheumatic diseases

Depression and anxiety are significantly associated with the introduction and switching of biologic DMARDs in patients with inflammatory rheumatic diseases, population-based study data show.

Latest from us on Twitter

Trending this week

Meet our Editorial Board

New Content Item Meet our Advisory Board

Image Credits